IN2014DE00822A - - Google Patents

Download PDF

Info

Publication number
IN2014DE00822A
IN2014DE00822A IN822DE2014A IN2014DE00822A IN 2014DE00822 A IN2014DE00822 A IN 2014DE00822A IN 822DE2014 A IN822DE2014 A IN 822DE2014A IN 2014DE00822 A IN2014DE00822 A IN 2014DE00822A
Authority
IN
India
Prior art keywords
subject
borapetoside
metabolite
prodrug
solvate
Prior art date
Application number
Other languages
English (en)
Inventor
Ming-Jai Su
Shoei-Sheng Lee
Original Assignee
Orient Europharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orient Europharma Co Ltd filed Critical Orient Europharma Co Ltd
Priority to IN822DE2014 priority Critical patent/IN2014DE00822A/en
Publication of IN2014DE00822A publication Critical patent/IN2014DE00822A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN822DE2014 2014-03-20 2014-03-20 IN2014DE00822A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN822DE2014 IN2014DE00822A (enrdf_load_stackoverflow) 2014-03-20 2014-03-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN822DE2014 IN2014DE00822A (enrdf_load_stackoverflow) 2014-03-20 2014-03-20

Publications (1)

Publication Number Publication Date
IN2014DE00822A true IN2014DE00822A (enrdf_load_stackoverflow) 2015-09-25

Family

ID=54394335

Family Applications (1)

Application Number Title Priority Date Filing Date
IN822DE2014 IN2014DE00822A (enrdf_load_stackoverflow) 2014-03-20 2014-03-20

Country Status (1)

Country Link
IN (1) IN2014DE00822A (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
ZA202308495B (en) Pharmaceutical compositions of therapeutically active compounds
SA521421115B1 (ar) عقاقير أولية من كربيدوبا وليفودوبا وطرق الاستخدام
PH12016501788B1 (en) Pharmaceutical compositions of therapeutically active compounds
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
MX2016011105A (es) Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos.
MX2016016388A (es) Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017014301A (es) Composiciones y metodos para el tratamiento o prevencion de hipertension pulmonar.
MY198753A (en) Treatment of androgen deprivation therapy associated symptoms
MX2016011706A (es) Formulaciones de progesterona.
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
IN2014DE00822A (enrdf_load_stackoverflow)
IN2014DE00818A (enrdf_load_stackoverflow)
PH12014000105A1 (en) Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
NZ725354A (en) Transdermal formulations of pergolide and uses thereof
EP3094330A4 (en) Treatment of crohn's disease using low doses of laquinimod
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.
ZA201606135B (en) Pharmaceutical compositions of therapeutically active compounds